CoChat

Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC‐cortical tubers

Toering, Sjoukje T., Boer, Karin, De Groot, Marjolein, Troost, Dirk, Heimans, Jan J., Spliet, Wim G. M., Van Rijen, Peter C., Jansen, Floor E., Gorter, Jan A., Reijneveld, Jaap C., Aronica, Eleonora · 2009 · Epilepsia
Cited by 56

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Summary: Purpose: Synaptic vesicle protein 2A (SV2A), the binding site for the antiepileptic drug (AED) levetiracetam, has been shown to be involved in the control of neuronal excitability. The aim of the study was to define the expression and cell‐specific distribution of SV2A in developmental focal lesions associated with medically intractable epilepsy. Methods: SV2A immunocytochemistry and Western blotting was performed in focal cortical dysplasia (FCD type IIB) and cortical tubers from patients with tuberous sclerosis complex (TSC). Results: Autopsy and surgical control neocortical specimens were characterized by strong SV2A immunoreactivity throughout all cortical layers, with punctate labeling around the somata and dendrites of neurons. In FCD and cortical tuber specimens less intense, SV2A immunoreactivity was observed in the neuropil. The reduction in expression was confirmed by Western blot analysis. In both FCD and tuber specimens, clusters of punctate labeling were detected along cell borders and processes (perisomatic synapses) of dysplastic neuronal cells localized in both gray and white matter. The large majority of balloon cells in FCD, or giant cells in tubers, did not show punctate labeling around their somata. SV2A immunoreactivity was observed occasionally within the neuronal perikarya. Conclusions: The pattern of SV2A immunoreactivity with reduced neuropil expression and altered cellular and subcellular distribution suggests a possible contribution of SV2A to the epileptogenicity of these malformations of cortical development. Knowledge of the expression pattern of SV2A in epilepsy‐associated pathologies may be valuable for the evaluation of the effectiveness of AEDs targeting this protein.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1528-1167.2008.01955.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 56

Metadata

Authors
Toering, S. T., Boer, K., De Groot, M., Troost, D., Heimans, J. J., Spliet, W. G. M., Van Rijen, P. C., Jansen, F. E., Gorter, J. A., Reijneveld, J. C., & Aronica, E.
Venue
Epilepsia
Publisher
Wiley
Published
2009-06
Volume
50
Issue
6
Pages
1409-1418
ISSN
  • 0013-9580 (ISSN-L)
  • 1528-1167
OpenAlex
W2145801192
Cited by
56
References
6
FWCI
2.40
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC‐cortical tubers. https://app.cochat.ai/papers/10.1111/j.1528-1167.2008.01955.x
The paper
Toering, S. T., Boer, K., De Groot, M., Troost, D., Heimans, J. J., Spliet, W. G. M., Van Rijen, P. C., Jansen, F. E., Gorter, J. A., Reijneveld, J. C., & Aronica, E. (2009). Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC‐cortical tubers. Epilepsia. https://doi.org/10.1111/j.1528-1167.2008.01955.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.